Dph2tm2(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
Dph2tm2(EUCOMM)Wtsi |
Name: |
DPH2 homolog; targeted mutation 2, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4840638 |
Gene: |
Dph2 Location: Chr4:117745838-117749220 bp, - strand Genetic Position: Chr4, 53.74 cM
|
Alliance: |
Dph2tm2(EUCOMM)Wtsi page
|
IMPC: |
Dph2 gene page |
|
Mutant Cell Lines: |
EPD0438_5_C04, EPD0438_5_G07 |
Germline Transmission: |
Earliest citation of germline transmission:
J:175295
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 1973 starting at position 117746669 and ending at position 117748642 of Chromosome 4 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:155845, J:173534)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Original: |
J:155845 Wellcome Trust Sanger Institute, Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2010; |
All: |
5 reference(s) |
|